Stock PATH UIPATH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus UiPath Inc.

Equities

PATH

US90364P1057

Market Closed - Nyse
Other stock markets
 04:00:03 2024-05-31 pm EDT 		After market 07:59:46 pm
12.26 USD +1.57% Intraday chart for UiPath Inc. 12.22 -0.29%
May. 30 Sector Update: Tech Stocks Mixed Late Afternoon MT
May. 30 Sector Update: Tech Stocks Mixed Thursday Afternoon MT

Evolution of the average Target Price on UiPath Inc.

Price target over the last 5 years

History of analyst recommendation changes

d87cca1.xiwvnsBmrg6i-2G2sZRiPRWwq_3wXBFQ6ybBDexZrsQ.t3V_0Ik-mFyTjiL9xcMRbFLm5rWpBlojgneJSN0h54CJS2jymVLkf8HMBg~c0ebfdffbcec135db4d70e439c3d1e8c

Analyst Recommendations on UiPath Inc.

BofA Securities Downgrades UiPath to Neutral From Buy, Cuts Price Target to $16 From $30; Shares Fall MT
Evercore ISI Cuts Price Target on UiPath to $13 From $27, Maintains In Line Rating MT
BofA Securities Downgrades UiPath to Neutral From Buy, Adjusts Price Target to $16 From $30 MT
Mizuho Adjusts Price Target on UiPath to $14 From $25, Maintains Neutral Rating MT
Needham Downgrades UiPath to Hold From Buy MT
William Blair Downgrades UiPath to Market Perform From Outperform MT
TD Cowen Downgrades UiPath to Hold From Buy, Price Target is $17 MT
RBC Cuts Price Target on UiPath to $19 From $24, Notes 'Execution Issues,' CEO Transition, Keeps Sector Perform Rating MT
Morgan Stanley Cuts Price Target on UiPath to $15 From $25, Calls Stock 'a Show-Me Story,' Keeps Equalweight Rating MT
Truist Downgrades UiPath to Hold From Buy After Disappointing Fiscal Q1 Results, Lowers Price Target to $14 From $32 MT
KeyBanc Downgrades UiPath to Sector Weight From Overweight, Removes $27 Price Target Amid Cut to Fiscal 2025 Guidance, CEO Resignation MT
Scotiabank Adjusts Price Target on UiPath to $25 From $30, Maintains Sector Perform Rating MT
RBC Lowers Price Target on UiPath to $24 From $29, Keeps Sector Perform Rating MT
UiPath Insider Sold Shares Worth $1,108,093, According to a Recent SEC Filing MT
Uipath Insider Sold Shares Worth $1,212,778, According to a Recent SEC Filing MT
KeyBanc Assumes UiPath at Overweight, Sets $27 Price Target, Sees UiPath Well-Positioned to Keep Driving Market Share Gains MT
Canaccord Genuity Raises Price Target on UiPath to $30 From $27, Maintains Buy Rating MT
Macquarie Raises Price Target on UiPath to $29 From $28 Citing Balanced Growth/Margin, Strong Cash Flows, Cloud ARR Momentum, Keeps Outperform Rating MT
Barclays Adjusts UiPath's Price Target to $25 From $23, Maintains Equalweight Rating MT
TD Cowen Adjusts UiPath's Price Target to $28 From $25, Maintains Outperform Rating MT
Evercore ISI Adjusts UiPath's Price Target to $27 From $24, Maintains In Line Rating MT
BMO Capital Raises Price Target on UiPath to $28 From $24, Maintains Market Perform Rating MT
Scotiabank Raises UiPath's Price Target to $30 From $29, Maintains Sector Perform Rating MT
BofA Securities Raises UiPath's Price Target to $30 From $26, Maintains Buy Rating MT
Mizuho Securities Raises UiPath's Price Target to $25 From $22, Maintains Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
12.26 USD
Average target price
17.82 USD
Spread / Average Target
+45.38%
High Price Target
29 USD
Spread / Highest target
+136.54%
Low Price Target
13 USD
Spread / Lowest Target
+6.04%

Consensus detail

Consensus revision (last 18 months)

Analysts covering UiPath Inc.

BofA Securities
Evercore ISI
Mizuho Securities
Needham & Co.
William Blair & Co.
TD Cowen
RBC Capital Markets
Morgan Stanley
Truist Securities
KeyBanc Capital Markets
Scotiabank
Canaccord Genuity
Macquarie
Barclays
BMO Capital
DA Davidson
Wells Fargo Securities
JPMorgan Chase
Credit Suisse
Oppenheimer
SMBC Nikko
Cowen
Berenberg Bank
Summit Insights Group
J.P. Morgan Chase
Wolfe Research

Ratings for UiPath Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PATH Stock
  4. Consensus UiPath Inc.